about
Effect of Carotene and Lycopene on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational StudiesRecurrent rearrangements in prostate cancer: causes and therapeutic potentialInterplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionEpigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentOverexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate CancerERG is a critical regulator of Wnt/LEF1 signaling in prostate cancerChromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genesAndrogen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development.DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cellsEvaluation of ERG responsive proteome in prostate cancerThe molecular basis for ethnic variation and histological subtype differences in prostate cancer.Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivationUsefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.Predominance of ERG-negative high-grade prostate cancers in African American men.Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.Resistance emerges to second-generation antiandrogens in prostate cancer.A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based studyERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer.Genomic rearrangements in prostate cancer.Prostate cancer in East Asia: evolving trend over the last decade.ERG oncoprotein inhibits ANXA2 expression and function in prostate cancerAnalytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.An update on PARP inhibitors for the treatment of cancerObesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate TumorsOncogenic activation of ERG: A predominant mechanism in prostate cancer.Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contextsGenomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers.The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP InhibitionCharacterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.Oncogene-mediated alterations in chromatin conformation
P2860
Q26786866-CA7342F3-F421-44C4-96BB-3CBAB5E3B087Q26851525-7EB78309-3EFA-4ACB-B3EE-DB0FB423BD4AQ27022288-5F6AD8DD-22B3-4B95-A589-EEC16CCD0EF0Q27323950-5FCD1576-B0F2-4991-BBA7-FFEF7D2C3FE5Q28076462-F7CB3239-647C-4FEF-BD90-A086BCB4D634Q28546607-C70B49C1-E4B1-48AD-A631-A3F51FA3CEFEQ28771736-71F964D7-901B-4044-9089-B23639D28A3DQ30414829-F9023AD6-D9BB-4121-9737-9F04BB247952Q33663401-308113F4-D401-4E4B-9DA6-9E67A732C971Q33682349-ADA8CC36-CE58-4C97-8F53-73DFA4A7BC51Q33805578-5A2DD430-B836-4DD8-9549-328E5F63A63EQ33822319-1D2B34B1-A4AD-4CF7-A09D-5BF8B9BCD18DQ33835864-FC38A30B-7F88-4F2B-8533-85E7BCE79C16Q34036065-8752024E-EB74-455C-A0F8-41A5E8DB7FACQ34036819-983028B8-6853-48CF-A022-2D702AEB2C5EQ34158217-8E50806D-6A8C-488C-B103-9BB522E8CB89Q34170544-0CC31E81-4B23-4C45-A8CE-F457139D758EQ34216236-CFD3B622-3420-4158-84E5-654B49C31F67Q34265721-159B565E-A0B2-41B2-9740-1BB0126235BFQ34287725-763D0F1B-9E83-4BC6-A47C-70BB23C675EFQ34369873-4CEED944-A0AE-4F23-9D6F-44B467418E83Q34501955-D4A438D0-B056-44C6-9899-D0844CE5E380Q34528257-49F2E2CB-244E-4496-9B2D-25C37B2AF941Q34652823-C1936568-78D2-4117-8D24-ECA2F14DE70DQ34722101-CFE09BC3-169D-4715-9BDE-E421140B41CEQ34927940-F1AFAE1D-BE49-457A-BF7B-A865D4FF8DBEQ35108911-8E725243-7A0F-48C0-A27A-C613ED8185C1Q35125405-7D94BD6C-507B-4E95-8A4F-4F5E7BE230BFQ35132292-98B2FDFC-87B6-4331-B230-B5AC5DC0BE6BQ35142718-A4066C3F-9EF7-4419-9D28-07A9AC3E6C38Q35535396-A41806CB-EB2C-422A-BC31-71F8BD1E388CQ35554127-C85A8C3D-C925-4619-88E8-8A7E98B2CCBBQ35555483-1F6174A6-E295-47C1-BBFE-3963B1209F44Q35631603-3CE85D7E-ED6F-4A7A-89F1-D9BE01486BCFQ35685920-4AB420B6-FAAA-4E7F-9BB5-CA1813156603Q35741647-33235CCC-4954-472B-929A-40929D73AFA9Q35771477-0CD46652-2AEB-4CFF-9B84-C5D5023BD022Q35930506-9F2818F9-4D72-43CC-99FA-F924ADE479F6Q36035812-07766F1B-3E0A-4852-BECA-461CFCC815F3Q36061468-25CE8829-05AE-480E-9EEB-4B018E30F8B9
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Common gene rearrangements in prostate cancer
@en
type
label
Common gene rearrangements in prostate cancer
@en
prefLabel
Common gene rearrangements in prostate cancer
@en
P2860
P356
P1476
Common gene rearrangements in prostate cancer
@en
P2093
Arul M Chinnaiyan
Christopher A Maher
P2860
P304
P356
10.1200/JCO.2011.35.1916
P407
P50
P577
2011-08-22T00:00:00Z